Algo version: 0.98b
Indoco Remedies Limited is listed at the NSE Exchange
Indoco Remedies Limited [INDOCO.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Indoco Remedies Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Indoco Remedies Limited pays dividends. Last time was Saturday 26th of October 2024 where the investors holding the stock on Thursday 19th of September 2024 were paid INR1.5 per share. Over the last 22 times between 2005 and 2024, Indoco Remedies Limited has paid INR44.6666 with an average of INR2.03 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Indoco Remedies Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR157.45, you would have made a profit of INR213.55 per share or 135.63%

Yes, the average daily trading liquidity for Indoco Remedies Limited is INR143 783 thousand. You should therefore be able to get in and out of your positions relatively fast.

Indoco Remedies Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.20, the company's ability to pay off the debt is normal. Indoco Remedies Limited has a good net profit margin of 5.47% and should have high tolerances against inflation.

We have calculated the inflation risk for Indoco Remedies Limited to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.